ON-DEMAND
12 Hours
On-Demand
12 Hours CE Credits
ON-DEMAND
12 Hours
On-Demand
12 Hours CE Credits
ON-DEMAND
12 Hours
On-Demand
12 Hours CE Credits
Play Trailer
Why This Course?
Why This Course?
Psychedelic therapy is reshaping how we address mental health and personal growth, offering new possibilities for healing trauma, fostering emotional resilience, and deepening self-awareness. However, entering this field requires a strong understanding of the science, context, and principles behind these therapies. This course offers a thoughtful introduction, helping you engage with this emerging discipline with clarity and care.
Learning Objectives
By completing this course, learners will be able to:
Identify the historical and contemporary context of psychedelic therapy, including key milestones in its development.
Describe the mechanisms of action of psychedelics and how they influence subjective experiences.
Explain the distinctions between classic psychedelics (e.g., psilocybin, LSD) and emerging therapies (e.g., ketamine, MDMA) within the context of their therapeutic applications.
Discuss the foundational principles of psychedelic harm reduction and integration as they relate to safe and effective therapeutic practices.
Describe the significance of set and setting in creating a safe and effective therapeutic environment for psychedelic-assisted therapy.
Identify key elements of the mystical experience and explain how it contributes to therapeutic outcomes in psychedelic-assisted therapy.
Explain the ethical considerations specific to psychedelic therapy, including its differences from traditional psychotherapy.
Analyze the role of cultural humility and strategies for addressing interracial trauma in the context of psychedelic therapy.
Discuss the preparation process for clients engaging in psychedelic therapy, including psychoeducation and informed consent practices.
Describe how to apply the “Ask-Tell-Ask” model for effective psychoeducation during preparation and integration.
Identify common challenges that arise during dosing sessions and explain strategies for supporting clients through difficult experiences.
Compare short-term and long-term integration approaches and their importance in achieving therapeutic outcomes in psychedelic therapy.
Describe the key principles of the Psychedelic Harm Reduction and Integration (PHRI) model, including its theoretical underpinnings and core concepts.
Explain the distinctions between preparation, assessment, and integration within the PHRI framework and how these phases support client safety and well-being.
Identify strategies for incorporating PHRI practices into clinical and non-clinical settings to support clients navigating psychedelic experiences.
Explain the mechanisms of action of ketamine, including its effects on the brain and body.
Describe the subjective effects of ketamine and how they relate to therapeutic outcomes.
Identify the clinical applications of Ketamine-Assisted Psychotherapy (KAP), including its use for treatment-resistant depression and other conditions.
Discuss the structural and therapeutic delivery of ketamine in clinical practice, as informed by insights from clinicians.
Evaluate strategies for incorporating ketamine into therapeutic practices while addressing safety, ethical considerations, and client preparation.
Describe the historical and contemporary research on psilocybin, including its primary therapeutic applications.
Explain the mechanisms of action and subjective effects of psilocybin as they relate to therapeutic outcomes.
Identify the unique features of psilocybin-assisted therapy for conditions such as depression and terminal illness.
Discuss the integration of psilocybin into Psychedelic Harm Reduction and Integration (PHRI) practices, with a focus on safety and client education.
Analyze the differences between psilocybin-assisted therapy in clinical research, state models, and facilitator contexts.
Evaluate the potential future roles of psilocybin in mental health care and its integration into broader therapeutic practices.
Describe the historical development of MDMA-assisted therapy (MDMA-AT) and its applications in treating PTSD and other conditions.
Explain the mechanisms of action and subjective effects of MDMA and how they contribute to therapeutic outcomes.
Discuss the MDMA-AT psychotherapeutic model, including its structure and delivery in clinical trials.
Analyze the ethical and practical considerations of implementing MDMA-assisted therapy in therapeutic practice.
Discuss the potential future integration of MDMA-AT into mainstream mental health care and its implications for therapeutic practice.
This course builds your theoretical foundation to help you explore the potential of psychedelic therapies in a responsible and informed way.
Professional Certificate Badge
Designed For
Licensed Mental Health Professionals
Curious Individuals
Industry Professionals
Topic
PHRI
Psychedelic Therapy
Ketamine
Psilocybin
MDMA
Type
On-Demand
Learning Objectives
By completing this course, learners will be able to:
Identify the historical and contemporary context of psychedelic therapy, including key milestones in its development.
Describe the mechanisms of action of psychedelics and how they influence subjective experiences.
Explain the distinctions between classic psychedelics (e.g., psilocybin, LSD) and emerging therapies (e.g., ketamine, MDMA) within the context of their therapeutic applications.
Discuss the foundational principles of psychedelic harm reduction and integration as they relate to safe and effective therapeutic practices.
Describe the significance of set and setting in creating a safe and effective therapeutic environment for psychedelic-assisted therapy.
Identify key elements of the mystical experience and explain how it contributes to therapeutic outcomes in psychedelic-assisted therapy.
Explain the ethical considerations specific to psychedelic therapy, including its differences from traditional psychotherapy.
Analyze the role of cultural humility and strategies for addressing interracial trauma in the context of psychedelic therapy.
Discuss the preparation process for clients engaging in psychedelic therapy, including psychoeducation and informed consent practices.
Describe how to apply the “Ask-Tell-Ask” model for effective psychoeducation during preparation and integration.
Identify common challenges that arise during dosing sessions and explain strategies for supporting clients through difficult experiences.
Compare short-term and long-term integration approaches and their importance in achieving therapeutic outcomes in psychedelic therapy.
Describe the key principles of the Psychedelic Harm Reduction and Integration (PHRI) model, including its theoretical underpinnings and core concepts.
Explain the distinctions between preparation, assessment, and integration within the PHRI framework and how these phases support client safety and well-being.
Identify strategies for incorporating PHRI practices into clinical and non-clinical settings to support clients navigating psychedelic experiences.
Explain the mechanisms of action of ketamine, including its effects on the brain and body.
Describe the subjective effects of ketamine and how they relate to therapeutic outcomes.
Identify the clinical applications of Ketamine-Assisted Psychotherapy (KAP), including its use for treatment-resistant depression and other conditions.
Discuss the structural and therapeutic delivery of ketamine in clinical practice, as informed by insights from clinicians.
Evaluate strategies for incorporating ketamine into therapeutic practices while addressing safety, ethical considerations, and client preparation.
Describe the historical and contemporary research on psilocybin, including its primary therapeutic applications.
Explain the mechanisms of action and subjective effects of psilocybin as they relate to therapeutic outcomes.
Identify the unique features of psilocybin-assisted therapy for conditions such as depression and terminal illness.
Discuss the integration of psilocybin into Psychedelic Harm Reduction and Integration (PHRI) practices, with a focus on safety and client education.
Analyze the differences between psilocybin-assisted therapy in clinical research, state models, and facilitator contexts.
Evaluate the potential future roles of psilocybin in mental health care and its integration into broader therapeutic practices.
Describe the historical development of MDMA-assisted therapy (MDMA-AT) and its applications in treating PTSD and other conditions.
Explain the mechanisms of action and subjective effects of MDMA and how they contribute to therapeutic outcomes.
Discuss the MDMA-AT psychotherapeutic model, including its structure and delivery in clinical trials.
Analyze the ethical and practical considerations of implementing MDMA-assisted therapy in therapeutic practice.
Discuss the potential future integration of MDMA-AT into mainstream mental health care and its implications for therapeutic practice.
This course builds your theoretical foundation to help you explore the potential of psychedelic therapies in a responsible and informed way.
Professional Certificate Badge
Designed For
Licensed Mental Health Professionals
Curious Individuals
Industry Professionals
Topic
PHRI
Psychedelic Therapy
Ketamine
Psilocybin
MDMA
Type
Courses
Learning Objectives
By completing this course, learners will be able to:
Identify the historical and contemporary context of psychedelic therapy, including key milestones in its development.
Describe the mechanisms of action of psychedelics and how they influence subjective experiences.
Explain the distinctions between classic psychedelics (e.g., psilocybin, LSD) and emerging therapies (e.g., ketamine, MDMA) within the context of their therapeutic applications.
Discuss the foundational principles of psychedelic harm reduction and integration as they relate to safe and effective therapeutic practices.
Describe the significance of set and setting in creating a safe and effective therapeutic environment for psychedelic-assisted therapy.
Identify key elements of the mystical experience and explain how it contributes to therapeutic outcomes in psychedelic-assisted therapy.
Explain the ethical considerations specific to psychedelic therapy, including its differences from traditional psychotherapy.
Analyze the role of cultural humility and strategies for addressing interracial trauma in the context of psychedelic therapy.
Discuss the preparation process for clients engaging in psychedelic therapy, including psychoeducation and informed consent practices.
Describe how to apply the “Ask-Tell-Ask” model for effective psychoeducation during preparation and integration.
Identify common challenges that arise during dosing sessions and explain strategies for supporting clients through difficult experiences.
Compare short-term and long-term integration approaches and their importance in achieving therapeutic outcomes in psychedelic therapy.
Describe the key principles of the Psychedelic Harm Reduction and Integration (PHRI) model, including its theoretical underpinnings and core concepts.
Explain the distinctions between preparation, assessment, and integration within the PHRI framework and how these phases support client safety and well-being.
Identify strategies for incorporating PHRI practices into clinical and non-clinical settings to support clients navigating psychedelic experiences.
Explain the mechanisms of action of ketamine, including its effects on the brain and body.
Describe the subjective effects of ketamine and how they relate to therapeutic outcomes.
Identify the clinical applications of Ketamine-Assisted Psychotherapy (KAP), including its use for treatment-resistant depression and other conditions.
Discuss the structural and therapeutic delivery of ketamine in clinical practice, as informed by insights from clinicians.
Evaluate strategies for incorporating ketamine into therapeutic practices while addressing safety, ethical considerations, and client preparation.
Describe the historical and contemporary research on psilocybin, including its primary therapeutic applications.
Explain the mechanisms of action and subjective effects of psilocybin as they relate to therapeutic outcomes.
Identify the unique features of psilocybin-assisted therapy for conditions such as depression and terminal illness.
Discuss the integration of psilocybin into Psychedelic Harm Reduction and Integration (PHRI) practices, with a focus on safety and client education.
Analyze the differences between psilocybin-assisted therapy in clinical research, state models, and facilitator contexts.
Evaluate the potential future roles of psilocybin in mental health care and its integration into broader therapeutic practices.
Describe the historical development of MDMA-assisted therapy (MDMA-AT) and its applications in treating PTSD and other conditions.
Explain the mechanisms of action and subjective effects of MDMA and how they contribute to therapeutic outcomes.
Discuss the MDMA-AT psychotherapeutic model, including its structure and delivery in clinical trials.
Analyze the ethical and practical considerations of implementing MDMA-assisted therapy in therapeutic practice.
Discuss the potential future integration of MDMA-AT into mainstream mental health care and its implications for therapeutic practice.
This course builds your theoretical foundation to help you explore the potential of psychedelic therapies in a responsible and informed way.
Professional Certificate Badge
Designed For
Licensed Mental Health Professionals
Curious Individuals
Industry Professionals
Topic
PHRI
Psychedelic Therapy
Ketamine
Psilocybin
MDMA
Type
On-Demand
Course Overview
The course is structured into seven chapters, each offering a clear focus on a key area of understanding:
Chapter 1
Introduction
An overview of the course framework, principles, and the evolving landscape of psychedelic therapy.
Chapter 3
Psychedelic Harm Reduction and Integration (PHRI) Therapy Fundamentals
An exploration of the principles of preparation, harm reduction, and integration as they relate to client care; How to help clients apply their experiences meaningfully in their lives while considering social, cultural, and ethical implications.
Chapter 5
Psilocybin
Insights into psilocybin’s mechanisms and its role in facilitating mystical and transformative experiences.
Chapter 2
Psychedelic Practice Fundamentals
Core concepts like “set and setting” and inner healing intelligence, and their role in creating safe and supportive environments.
Chapter 4
Ketamine
A look at ketamine’s therapeutic applications, from treating depression to alleviating anxiety and trauma.
Chapter 6
MDMA
An introduction to MDMA’s use in addressing PTSD and fostering emotional connection and healing.
Chapter 7
Other Molecules & Next Steps
Highlights professional applications of course knowledge, additional Fluence offerings, and opportunities for continued learning, concluding with gratitude and an invitation to collaborate.
Course Overview
The course is structured into seven chapters, each offering a clear focus on a key area of understanding:
Chapter 1
Introduction
An overview of the course framework, principles, and the evolving landscape of psychedelic therapy.
Chapter 3
Psychedelic Harm Reduction and Integration (PHRI) Therapy Fundamentals
An exploration of the principles of preparation, harm reduction, and integration as they relate to client care; How to help clients apply their experiences meaningfully in their lives while considering social, cultural, and ethical implications.
Chapter 5
Psilocybin
Insights into psilocybin’s mechanisms and its role in facilitating mystical and transformative experiences.
Chapter 2
Psychedelic Practice Fundamentals
Core concepts like “set and setting” and inner healing intelligence, and their role in creating safe and supportive environments.
Chapter 4
Ketamine
A look at ketamine’s therapeutic applications, from treating depression to alleviating anxiety and trauma.
Chapter 6
MDMA
An introduction to MDMA’s use in addressing PTSD and fostering emotional connection and healing.
Chapter 7
Other Molecules & Next Steps
Highlights professional applications of course knowledge, additional Fluence offerings, and opportunities for continued learning, concluding with gratitude and an invitation to collaborate.
Course Overview
The course is structured into seven chapters, each offering a clear focus on a key area of understanding:
Chapter 1
Introduction
An overview of the course framework, principles, and the evolving landscape of psychedelic therapy.
Chapter 3
Psychedelic Harm Reduction and Integration (PHRI) Therapy Fundamentals
An exploration of the principles of preparation, harm reduction, and integration as they relate to client care; How to help clients apply their experiences meaningfully in their lives while considering social, cultural, and ethical implications.
Chapter 5
Psilocybin
Insights into psilocybin’s mechanisms and its role in facilitating mystical and transformative experiences.
Chapter 2
Psychedelic Practice Fundamentals
Core concepts like “set and setting” and inner healing intelligence, and their role in creating safe and supportive environments.
Chapter 4
Ketamine
A look at ketamine’s therapeutic applications, from treating depression to alleviating anxiety and trauma.
Chapter 6
MDMA
An introduction to MDMA’s use in addressing PTSD and fostering emotional connection and healing.
Chapter 7
Other Molecules & Next Steps
Highlights professional applications of course knowledge, additional Fluence offerings, and opportunities for continued learning, concluding with gratitude and an invitation to collaborate.
Take the First Step
Join a growing community of professionals and learners committed to exploring the future of mental health care.
On-Demand
12 Hours
12 Hours CE Credits
Grow your practice.
Get certified and join the Fluence Psychedelic Therapy Directory—where clients find trusted experts.
Grow your practice.
Get certified and join the Fluence Psychedelic Therapy Directory—where clients find trusted experts.
Grow your practice.
Get certified and join the Fluence Psychedelic Therapy Directory—where clients find trusted experts.
What students have to say about this program...
I really appreciate Fluence. The trainings and coursework, the literature shared, the community, self-development and insightful explorations have strengthened me as a professional and given such a sense of competence in this evolving space.
Amy Johnson
LCSW
I've been more than thrilled about my experience with Fluence thus far. I am a ketamine-assisted psychotherapist and
continue to learn more information and modalities to incorporate into my practice, from both the instructors and
fellow students.
LAURA HUTCHINS,
LCMHC, LCAS, KAP Consulting
My entire experience with Fluence has been exceptional. The instructors are giants in the psychedelic field, many are active in clinical research and you will see their names in scientific publications.
Stephanie Barss,
FNP, PMHNP, Psilocybin-Assisted Therapy
Certificate Program Advisor
The trainers at Fluence are what continually confirm that I am in the right place. The reverence and honor with which they approach their work is so evident. I have felt a sense of safety
at Fluence that is not present in other organizations I have
trained with or researched, and it is the trainers who create that safety.
Andrea Bigenho,
LPC specialist in Psychedelic Integration
What are students say…
I really appreciate Fluence. The trainings and coursework, the literature shared, the community, self-development and insightful explorations have strengthened me as a professional and given such a sense of competence in this evolving space.
Amy Johnson,
LCSW
What students have to say about this program...
I really appreciate Fluence. The trainings and coursework, the literature shared, the community, self-development and insightful explorations have strengthened me as a professional and given such a sense of competence in this evolving space.
Amy Johnson,
LCSW
Authorized provider of continuing education.
Fluence is approved by the American Psychological Association to sponsor continuing education for psychologists.
Fluence maintains responsibility for this program and its content.
Authorized provider of continuing education.
Fluence is approved by the American Psychological Association to sponsor continuing education for psychologists.
Fluence maintains responsibility for this program and its content.
Authorized provider of continuing education.
Fluence is approved by the American Psychological Association to sponsor continuing education for psychologists.
Fluence maintains responsibility for this program and its content.
FAQs
What can I practice with this certificate?
This introduction course is designed for all psychedelic stakeholders - from psychedelic enthusiasts to psychotherapists. Licensed mental health practitioners who are interested in continuing beyond this introduction course receive a discount on when enrolling in the Professional Certificate of their choice.
Who is this program for?
What are the enrollment requirements?
How is the course structured?
How do I access course materials?
Sneak Peek into the Classroom
FAQs
What can I practice with this certificate?
This introduction course is designed for all psychedelic stakeholders - from psychedelic enthusiasts to psychotherapists. Licensed mental health practitioners who are interested in continuing beyond this introduction course receive a discount on when enrolling in the Professional Certificate of their choice.
Who is this program for?
What are the enrollment requirements?
How is the course structured?
How do I access course materials?
Sneak Peek into the Classroom
FAQs
What can I practice with this certificate?
This introduction course is designed for all psychedelic stakeholders - from psychedelic enthusiasts to psychotherapists. Licensed mental health practitioners who are interested in continuing beyond this introduction course receive a discount on when enrolling in the Professional Certificate of their choice.
Who is this program for?
What are the enrollment requirements?
How is the course structured?
How do I access course materials?
Sneak Peek into the Classroom
Have questions? Ask our experts.
Have questions?
Ask our experts.
Have questions? Ask our experts.
Subscribe to our newsletter!
Professional Certificates
Subscribe to our newsletter!
Professional Certificates
Subscribe to our newsletter!
Professional Certificates